What is the ROE (Return on Equity) of OPKO Health this year?
The ROE of OPKO Health this year is -0.14 undefined.
OPKO Health ROE 2024
OPKO Health ROE
-0.14
Ticker
OPK
ISIN
US68375N1037
WKN
A0MUUJ
In 2024, OPKO Health's return on equity (ROE) was -0.14, a -35.35% increase from the -0.21 ROE in the previous year.
OPKO Health Aktienanalyse
What does OPKO Health do?
OPKO Health Inc is an American company specializing in diagnostics, biopharmaceuticals, and pharmaceutical products. It was founded in 1991 by Dr. Phillip Frost, who still serves as CEO. The company is headquartered in Miami, Florida, and employs around 6,000 people worldwide. In recent years, OPKO Health Inc has undergone strong expansion, particularly through several acquisitions of other companies. These include Bio-Reference Laboratories, Inc., a leading provider of diagnostic services, and EirGen Pharma, a European company specializing in the production of high-quality pharmaceuticals. The business model of OPKO Health Inc is based on the development and marketing of products and services in the field of diagnostics and medical research. The company operates numerous state-of-the-art laboratories worldwide, which conduct diagnostic tests, genetic analyses, and medical research. OPKO Health Inc offers a wide range of products and services distributed across multiple business areas. One important area is the diagnostics division, which offers a wide range of tests and services, including cancer diagnostics, blood tests, genetic analyses, and clinical trials. Another important business area of OPKO Health Inc is the biopharmaceutical division, which focuses on the development and marketing of innovative therapies and medical products. The company develops medications against cancer and other diseases, as well as vaccines and immunological therapies. A third important business area of OPKO Health Inc is the pharmaceutical products division, which specializes in the production and distribution of pharmaceutical products and generic medications. The company has a broad portfolio of products, ranging from over-the-counter painkillers to medications for rare diseases. One of OPKO Health Inc's key products is the 4Kscore test, a blood test for diagnosing prostate cancer. This test is approved in the US and Europe and has a high accuracy rate in detecting aggressive forms of cancer. Another important product of the company is Rayaldee-Tabs, an innovative vitamin D medication used for the treatment of patients with chronic kidney disease (CKD). The medication has shown high efficacy in clinical studies and is currently approved in the US and Europe. OPKO Health Inc has become a significant player in the field of medical research and diagnostics through strong expansion and numerous acquisitions in recent years. The company focuses on high quality and innovative technologies to best support its customers worldwide. OPKO Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROE Details
Decoding OPKO Health's Return on Equity (ROE)
OPKO Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.
Year-to-Year Comparison
Analyzing OPKO Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.
Impact on Investments
OPKO Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.
Interpreting ROE Fluctuations
Changes in OPKO Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.
Frequently Asked Questions about OPKO Health stock
How has the Return on Equity (ROE) of OPKO Health developed compared to the previous year?
The ROE of OPKO Health has increased by -35.35% decreased compared to the previous year.
What impact does a high ROE (Return on Equity) have on investors of OPKO Health?
A high ROE indicates that OPKO Health generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.
What impact does a low ROE (Return on Equity) have on investors of OPKO Health?
A low ROE can indicate that OPKO Health is having difficulties monetizing its investments successfully and can be a negative signal for investors.
How does a change in the ROE (Return on Equity) of OPKO Health affect the company?
A change in ROE (Return on Equity) of OPKO Health can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.
How to calculate the ROE (Return on Equity) of OPKO Health?
The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.
Which factors influence the ROE (Return on Equity) of OPKO Health?
Some factors that can influence OPKO Health's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.
What strategic measures can take to improve the ROE (Return on Equity)?
To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.
How much dividend does OPKO Health pay?
Over the past 12 months, OPKO Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, OPKO Health is expected to pay a dividend of 0 USD.
What is the dividend yield of OPKO Health?
The current dividend yield of OPKO Health is .
When does OPKO Health pay dividends?
OPKO Health pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of OPKO Health?
OPKO Health paid dividends every year for the past 0 years.
What is the dividend of OPKO Health?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is OPKO Health located?
OPKO Health is assigned to the 'Health' sector.
Wann musste ich die Aktien von OPKO Health kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of OPKO Health from 9/27/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/27/2024.
When did OPKO Health pay the last dividend?
The last dividend was paid out on 9/27/2024.
What was the dividend of OPKO Health in the year 2023?
In the year 2023, OPKO Health distributed 0 USD as dividends.
In which currency does OPKO Health pay out the dividend?
The dividends of OPKO Health are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The OPKO Health stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von OPKO Health
Our stock analysis for OPKO Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of OPKO Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
